Special Issue
Topic: Immune Subtypes and Immunotherapeutic Responses in Malignancies
A Special Issue of Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)
Submission deadline: 15 Jul 2024
Guest Editor(s)
Prof. Xiaobing Chen
Department of Internal Medicine, Henan Cancer Hospital, Zhengzhou University, Zhengzhou, China.
Prof. Hongda Liu
Department of General Surgery, First Affiliated Hospital, Nanjing Medical University, Nanjing, China.
Special Issue Introduction
This topic aims to explore the immune microenvironment of cancers through multi-omics analyses, so as to provide reference for precise treatment of cancer. We welcome the submission of original research and review articles that include biomarkers in clinical studies and applications, as well as technologies or discoveries in experimental approaches.
Potential topics include but are not limited to the following:
1. Proteomics, transcriptome analysis, single cell sequencing analysis and other high-throughput approaches to define distinct immunological subtypes of cancer.
2. Transcriptome and single-cell sequencing studies that help discover new cancer prognostic markers, associated prognostic signatures, and immunotherapy prediction.
3. Investigating carcinogenicity of environmental disruptors, their potential detrimental influences on human immune system, and crosstalk with cancer immunity.
4. Genetic vaccine for the effective cancer treatment as a novel immune therapy.
5. Single-cell sequencing and spatial transcriptome analysis to clarify the spatial localization relationship between cells, explore the potential immune mechanism of tumors.
6. Novel high-throughput screening methodologies for mapping cancer landscape.
Potential topics include but are not limited to the following:
1. Proteomics, transcriptome analysis, single cell sequencing analysis and other high-throughput approaches to define distinct immunological subtypes of cancer.
2. Transcriptome and single-cell sequencing studies that help discover new cancer prognostic markers, associated prognostic signatures, and immunotherapy prediction.
3. Investigating carcinogenicity of environmental disruptors, their potential detrimental influences on human immune system, and crosstalk with cancer immunity.
4. Genetic vaccine for the effective cancer treatment as a novel immune therapy.
5. Single-cell sequencing and spatial transcriptome analysis to clarify the spatial localization relationship between cells, explore the potential immune mechanism of tumors.
6. Novel high-throughput screening methodologies for mapping cancer landscape.
Keywords
Immunotherapeutic, oncology, multi-omics, single cell sequencing, proteomics, transcriptome.
Submission Deadline
15 Jul 2024
Submission Information
For Author Instructions, please refer to https://www.oaepublish.com/jcmt/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=jcmt&SpecialIssueId=jcmt202304281
Submission Deadline: 15 Jul 2024
Contacts: Wendy Liu, Assistant Editor, wendy@oaeservice.com
Published Articles
Cancer-associated fibroblasts (CAFs) based model reveals potential for predicting bladder cancer patients’ prognoses and immunotherapy responses
Open Access Original Article 18 Feb 2024
Views: Downloads: